Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs
Zhou Zhou, Claire Dunn, Ibrahim Khadra, et al.
European Journal of Pharmaceutical Sciences (2016) Vol. 99, pp. 95-104
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
Zahari Vinarov, Mohammad Abdallah, José A. G. Agúndez, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 162, pp. 105812-105812
Open Access | Times Cited: 226
Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs
Giovana Carolina Bazzo, Bianca Ramos Pezzini, Hellen Karine Stulzer
International Journal of Pharmaceutics (2020) Vol. 588, pp. 119741-119741
Closed Access | Times Cited: 112
Automated assays for thermodynamic (equilibrium) solubility determination
Tomás Sou, Christel A. S. Bergström
Drug Discovery Today Technologies (2018) Vol. 27, pp. 11-19
Open Access | Times Cited: 55
Effect of Surfactant–Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media
Zahari Vinarov, Vladimir Katev, Nikola Burdzhiev, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 12, pp. 5741-5753
Closed Access | Times Cited: 41
Oral andrographolide loaded lipid nanocarriers alleviate stress behaviors and hippocampal damage in TNF alpha induced neuroinflammatory mice
Sarawut Lapmanee, Natchanon Rimsueb, Phichaporn Bunwatcharaphansakun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Multidimensional analysis of human intestinal fluid composition
Kate Pyper, Joachim Brouwers, Patrick Augustijns, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 153, pp. 226-240
Open Access | Times Cited: 28
Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These Changes
Domagoj Šegregur, Talia Flanagan, James Mann, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 108, Iss. 11, pp. 3461-3477
Closed Access | Times Cited: 28
Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states
Chara Litou, Nikunjkumar Patel, David B. Turner, et al.
European Journal of Pharmaceutical Sciences (2019) Vol. 138, pp. 105031-105031
Open Access | Times Cited: 26
Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project
Bertil Abrahamsson, Mark McAllister, Patrick Augustijns, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 152, pp. 236-247
Open Access | Times Cited: 25
Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design
Zhou Zhou, Claire Dunn, Ibrahim Khadra, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4132-4144
Open Access | Times Cited: 28
Exploring drug solubility in fasted human intestinal fluid aspirates: Impact of inter-individual variability, sampling site and dilution
Mariangeles Pérez de la Cruz-Moreno, Consuelo Montejo, Antonio Aguilar, et al.
International Journal of Pharmaceutics (2017) Vol. 528, Iss. 1-2, pp. 471-484
Closed Access | Times Cited: 27
Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs
Jérémy Perrier, Zhou Zhou, Claire Dunn, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 111, pp. 247-256
Open Access | Times Cited: 25
In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development
Patricia Zane, Hille Gieschen, Elisabeth Kersten, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 222-231
Closed Access | Times Cited: 23
Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid
Stephanie Sammartino McPherson, Jérémy Perrier, Claire Dunn, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 150, pp. 14-23
Closed Access | Times Cited: 21
Mixed micellization of bile salts and transglycosylated stevia and enhanced binding and solubility of non-steroidal anti-inflammatory drugs using mixed micelle
Anirudh Srivastava, Osvaldo Yáñez, Plinio Cantero-López
Journal of Molecular Liquids (2020) Vol. 311, pp. 113341-113341
Closed Access | Times Cited: 21
Supramolecular self-assembly strategy for the enhanced solubility/dissolution rate and anti-cancer efficacy of osimertinib: Insights from multi-component crystals to drug chemistry
Xiaoxiao Liang, Yanru Wu, Yuehua Deng, et al.
Chemical Engineering Science (2024) Vol. 299, pp. 120520-120520
Closed Access | Times Cited: 2
Topography of Simulated Intestinal Equilibrium Solubility
Claire Dunn, Jérémy Perrier, Ibrahim Khadra, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 5, pp. 1890-1905
Open Access | Times Cited: 19
The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol
Rania Hamed, Sabreen Hasan Alnadi, Areeg Awadallah
AAPS PharmSciTech (2020) Vol. 21, Iss. 5
Closed Access | Times Cited: 17
Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs
Teruo Murakami, Erik T. Bodor, Nicholas Bodor
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 5, pp. 555-580
Closed Access | Times Cited: 15
Human intestinal fluid factors affecting intestinal drug permeation in vitro
Danny Riethorst, Joachim Brouwers, Jens Motmans, et al.
European Journal of Pharmaceutical Sciences (2018) Vol. 121, pp. 338-346
Open Access | Times Cited: 18
Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid
Bayan E. Ainousah, Jérémy Perrier, Claire Dunn, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4170-4180
Open Access | Times Cited: 17
Physiological parameters of the gastrointestinal fluid impact the dissolution behavior of the BCS class IIa drug valsartan
Rania Hamed
Pharmaceutical Development and Technology (2018) Vol. 23, Iss. 10, pp. 1168-1176
Closed Access | Times Cited: 17
An interlaboratory investigation of intrinsic dissolution rate determination using surface dissolution
Kelly Etherson, Claire Dunn, W. Stephen Matthews, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 150, pp. 24-32
Open Access | Times Cited: 15
Gastrointestinal diseases and their impact on drug solubility: Crohn's disease
Angela Effinger, Caitríona M. O’Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 152, pp. 105459-105459
Open Access | Times Cited: 15
Fed intestinal solubility limits and distributions applied to the Developability classification system
Maria Inês Silva, Ibrahim Khadra, Kate Pyper, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 186, pp. 74-84
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top